Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-29 01:08:13 - browse：11

An ALS patient receives support. -- health coverage from STAT — Adobe

Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn, a potential treatment to slow the progression of ALS that has bitterly divided physicians and patient advocates.

On Sept. 27, a panel of experts will consider the convoluted data supporting the potential approval of NurOwn, a stem-cell therapy the FDA previously refused to even consider. To some physicians, the drug’s failure to show significant benefits in clinical studies leaves approval out of the question. Others, including the influential ALS Association, say NurOwn’s manufacturer, a small biotech firm called BrainStorm Cell Therapeutics, hasn’t disclosed enough information to properly determine the medicine’s value.

Another group of patients and doctors argue that NurOwn’s supporting evidence, while problematic, justifies making it available to the roughly 30,000 ALS patients in the U.S., people for whom there is currently no hope of arresting an incurable disease that gradually erodes motor function and leads to death within about five years of diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： CDC picks Alphabet's Verily for wasterwater surveillance contract

Wikipedia

focus

WSS

GSK to buy asthma

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

European officials brace for rough respiratory virus season

The Karikó problem: Lessons for funding basic research

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Nobel honors Karikó and Weissman's enduring partnership

hotspot

Wikipedia

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Apple is now the first public company to be valued at $3 trillion

With Roe v Wade overturned, abortion providers work to adapt

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

WHO recommends second malaria vaccine

Hepatitis C has a cure — but many Americans still lack access to it

New Medicare drug pricing powers could soon be upended in court

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The Karikó problem: Lessons for funding basic research

explore

Study points to new risk in gene therapy death of Terry Horgan

Some top drug companies are starting to take action on climate

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Heart disease and mental health: A look at cardiac psychology

European officials brace for rough respiratory virus season

Heart disease and mental health: A look at cardiac psychology

Wikipedia

entertainment

focus

knowledge